» Articles » PMID: 34350377

Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care

Overview
Specialty Oncology
Date 2021 Aug 5
PMID 34350377
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In a time of rapid advances in science and technology, the opportunities for radiation oncology are undergoing transformational change. The linkage between and understanding of the physical dose and induced biological perturbations are opening entirely new areas of application. The ability to define anatomic extent of disease and the elucidation of the biology of metastases has brought a key role for radiation oncology for treating metastatic disease. That radiation can stimulate and suppress subpopulations of the immune response makes radiation a key participant in cancer immunotherapy. Targeted radiopharmaceutical therapy delivers radiation systemically with radionuclides and carrier molecules selected for their physical, chemical, and biochemical properties. Radiation oncology usage of "big data" and machine learning and artificial intelligence adds the opportunity to markedly change the workflow for clinical practice while physically targeting and adapting radiation fields in real time. Future precision targeting requires multidimensional understanding of the imaging, underlying biology, and anatomical relationship among tissues for radiation as spatial and temporal "focused biology." Other means of energy delivery are available as are agents that can be activated by radiation with increasing ability to target treatments. With broad applicability of radiation in cancer treatment, radiation therapy is a necessity for effective cancer care, opening a career path for global health serving the medically underserved in geographically isolated populations as a substantial societal contribution addressing health disparities. Understanding risk and mitigation of radiation injury make it an important discipline for and beyond cancer care including energy policy, space exploration, national security, and global partnerships.

Citing Articles

NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy.

Paganetti H, Simone 2nd C, Bosch W, Haas-Kogan D, Kirsch D, Li H Int J Radiat Oncol Biol Phys. 2024; 121(1):202-217.

PMID: 39059509 PMC: 11646189. DOI: 10.1016/j.ijrobp.2024.07.2152.


The National Cancer Institute's Cancer Disparities Research Partnership Program: a unique funding model 20 years later.

Coleman C, Wong R, Petereit D, Maguire P, Heron D, Steinberg M J Natl Cancer Inst. 2023; 115(12):1465-1474.

PMID: 37707545 PMC: 10699796. DOI: 10.1093/jnci/djad173.


Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer.

Sapir E, Cherny N, Ennis R, Smith B, Smith G, Marks L ESMO Open. 2023; 8(3):101206.

PMID: 37236087 PMC: 10265604. DOI: 10.1016/j.esmoop.2023.101206.


Inter-agency perspective: Translating advances in biomarker discovery and medical countermeasures development between terrestrial and space radiation environments.

DiCarlo A, Carnell L, Rios C, Prasanna P Life Sci Space Res (Amst). 2022; 35:9-19.

PMID: 36336375 PMC: 9832585. DOI: 10.1016/j.lssr.2022.06.004.


Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.

Buchsbaum J, Espey M, Obcemea C, Capala J, Ahmed M, Prasanna P J Clin Oncol. 2022; 40(17):1861-1869.

PMID: 35245101 PMC: 9177246. DOI: 10.1200/JCO.21.02579.

References
1.
Oar A, Yap M, Rodin D, McNiven A, Papadakos J, Giuliani M . Postgraduate Global Health Competency Profile for Radiation Oncology. Clin Oncol (R Coll Radiol). 2018; 30(12):810-816. DOI: 10.1016/j.clon.2018.08.019. View

2.
Barth R, Mi P, Yang W . Boron delivery agents for neutron capture therapy of cancer. Cancer Commun (Lond). 2018; 38(1):35. PMC: 6006782. DOI: 10.1186/s40880-018-0299-7. View

3.
Faddegon B, Ramos-Mendez J, Schuemann J, McNamara A, Shin J, Perl J . The TOPAS tool for particle simulation, a Monte Carlo simulation tool for physics, biology and clinical research. Phys Med. 2020; 72:114-121. PMC: 7192305. DOI: 10.1016/j.ejmp.2020.03.019. View

4.
Prasanna P, Narayanan D, Zhang K, Rahbar A, Coleman C, Vikram B . Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?. Radiat Res. 2020; 193(3):199-208. DOI: 10.1667/RR15553.1. View

5.
Citrin D, Prasanna P, Walker A, Freeman M, Eke I, Barcellos-Hoff M . Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. Radiat Res. 2017; 188(1):1-20. PMC: 5558616. DOI: 10.1667/RR14784.1. View